{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:30:12Z","timestamp":1787243412653,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.neurol.2024.02.392","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:18:23Z","timestamp":1712341103000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9736-2664","authenticated-orcid":false,"given":"S.","family":"Keovilayhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mulliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Feral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chenaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clavelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Moisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Taithe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1934-3832","authenticated-orcid":false,"given":"L.","family":"Poncet Megemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2024.02.392_bib0210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0215","volume":"vol. 2","author":"Joseph","year":"2021"},{"key":"10.1016\/j.neurol.2024.02.392_bib0220","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","article-title":"Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis","volume":"19","author":"Salari","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.neurol.2024.02.392_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurol.2024.02.392_bib0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2024.02.392_bib0240","doi-asserted-by":"crossref","first-page":"e01819","DOI":"10.1002\/brb3.1819","article-title":"Epidemiology of myasthenia gravis in Sweden 2006\u20132016","volume":"10","author":"Westerberg","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.neurol.2024.02.392_bib0245","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.47.5.1233","article-title":"Epidemiologic evidence for a changing natural history of myasthenia gravis","volume":"47","author":"Phillips","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.02.392_bib0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829593","article-title":"The epidemiology of myasthenia gravis","volume":"24","author":"Phillips","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0255","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","article-title":"Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing: late-onset MG","volume":"48","author":"Alkhawajah","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2024.02.392_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neurol.2024.02.392_bib0265","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2024.02.392_bib0270","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/pgmj.2004.018903","article-title":"Update on myasthenia gravis","volume":"80","author":"Thanvi","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.neurol.2024.02.392_bib0275","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: immunological and clinical aspects: paraneoplastic MG: immunological and clinicial aspects","volume":"15","author":"Skeie","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0280","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0285","doi-asserted-by":"crossref","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","article-title":"Geoepidemiology of myasthenia gravis","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.neurol.2024.02.392_bib0290","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG: characteristics and long-term outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.02.392_bib0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0300","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/ene.14730","article-title":"Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: a Swedish nationwide register study","volume":"28","author":"Verwijst","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0305","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7","article-title":"Thymoma is associated with an increased risk of second malignancy","volume":"92","author":"Pan","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.neurol.2024.02.392_bib0310","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/mus.27369","article-title":"Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis","volume":"64","author":"Vijayan","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2024.02.392_bib0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The epidemiology of myasthenia gravis in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.neurol.2024.02.392_bib0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000311012","article-title":"Nationwide population-based epidemiological study of myasthenia gravis in Taiwan","volume":"35","author":"Lai","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurol.2024.02.392_bib0325","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.1912","article-title":"Pharmacoepidemiological research using French reimbursement databases: yes we can!","volume":"19","author":"Martin-Latry","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.neurol.2024.02.392_bib0330","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.amjcard.2017.12.013","article-title":"Effect of optimization of medical treatment on long-term survival of patients with heart failure after implantable cardioverter defibrillator and cardiac resynchronization device implantation (from the French National EGB Database)","volume":"121","author":"Massoulli\u00e9","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0335","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bcp.14449","article-title":"Trajectories of antidepressant drugs during pregnancy: a cohort study from a community-based sample","volume":"87","author":"Cabaillot","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0340","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s10286-008-0476-x","article-title":"Pilot study of pyridostigmine in constipated patients with autonomic neuropathy","volume":"18","author":"Bharucha","year":"2008","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.neurol.2024.02.392_bib0345","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.neurol.2024.02.392_bib0350","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1536867X1201200408","article-title":"A command to calculate age-standardized rates with efficient interval estimation","volume":"12","author":"Consonni","year":"2012","journal-title":"Stata J Promot Commun Stat Stata"},{"key":"10.1016\/j.neurol.2024.02.392_bib0355","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e318217e735","article-title":"Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada","volume":"76","author":"Pakzad","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.02.392_bib0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"Evidence of underdiagnosis of myasthenia gravis in older people","volume":"74","author":"Vincent","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2024.02.392_bib0365","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/jnnp.2008.152637","article-title":"Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan","volume":"80","author":"Matsui","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2024.02.392_bib0370","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ando.2010.06.006","article-title":"Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily","volume":"71","author":"Rizzo","year":"2010","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0380","doi-asserted-by":"crossref","first-page":"e55450","DOI":"10.1371\/journal.pone.0055450","article-title":"Hashimoto's thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer","volume":"8","author":"Latina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2024.02.392_bib0385","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14309\/ajg.0000000000000523","article-title":"Incidence of celiac disease is increasing over time: a systematic review and meta-analysis","volume":"115","author":"King","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.neurol.2024.02.392_bib0395","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/ene.12383","article-title":"Myasthenia and risk of cancer: a population-based case-control study","volume":"21","author":"Pedersen","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0400","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1468-1331.2011.03621.x","article-title":"Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study: extrathymic cancer risk in patients with myasthenia gravis","volume":"19","author":"Liu","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2024.02.392_bib0405","first-page":"372","article-title":"National estimates of cancer incidence and mortality in metropolitan France between 1990 and 2018","volume":"1","author":"Defossez","year":"2019","journal-title":"Sante Publique France"},{"key":"10.1016\/j.neurol.2024.02.392_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3917\/pos.403.0213","article-title":"L\u2019\u00e9chantillon g\u00e9n\u00e9raliste de b\u00e9n\u00e9ficiaires\u00a0: repr\u00e9sentativit\u00e9, port\u00e9e et limites","volume":"40","author":"Roquefeuil","year":"2009","journal-title":"Prat Organ Soins"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724004855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724004855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:18:30Z","timestamp":1716585510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378724004855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0035378724004855"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.02.392","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.02.392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}